 | • レポートコード：MRC2Q12-03736 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、タクロリムスAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 タクロリムスAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 タクロリムスAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 タクロリムスAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのタクロリムスAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のタクロリムスAPIの売上および2028年までの予測に焦点を当てています。 タクロリムスAPIのグローバル主要企業には、Hangzhou Zhongmei Huadong Pharmaceutical、Guangzhou Tosun Pharmaceutical、Chunghwa Chemical Synthesis & Biotech、ChemWerth Inc、Dr. Reddy's Laboratories、Zeon Health Industries、Fishfa Biogenics、Teva API、Apotex Fermentation Inc.、Astellas Pharma、Bills Biotech、CKD Bio Corporation、Concord Biotech、JOYANG LABORATORIES、Lek Pharmaceuticals、Murli Krishna Pharma、Viruj Pharmaceuticals Pvt. Ltd、Zhejiang Hisun Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 タクロリムスAPI市場は、タイプとアプリケーションによって区分されます。世界のタクロリムスAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.98、0.99、その他 【アプリケーション別セグメント】 カプセル剤、注射剤、軟膏剤、点眼剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - タクロリムスAPI製品概要 - タイプ別市場（0.98、0.99、その他） - アプリケーション別市場（カプセル剤、注射剤、軟膏剤、点眼剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のタクロリムスAPI販売量予測2017-2028 - 世界のタクロリムスAPI売上予測2017-2028 - タクロリムスAPIの地域別販売量 - タクロリムスAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別タクロリムスAPI販売量 - 主要メーカー別タクロリムスAPI売上 - 主要メーカー別タクロリムスAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.98、0.99、その他） - タクロリムスAPIのタイプ別販売量 - タクロリムスAPIのタイプ別売上 - タクロリムスAPIのタイプ別価格 ・アプリケーション別市場規模（カプセル剤、注射剤、軟膏剤、点眼剤、その他） - タクロリムスAPIのアプリケーション別販売量 - タクロリムスAPIのアプリケーション別売上 - タクロリムスAPIのアプリケーション別価格 ・北米市場 - 北米のタクロリムスAPI市場規模（タイプ別、アプリケーション別） - 主要国別のタクロリムスAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのタクロリムスAPI市場規模（タイプ別、アプリケーション別） - 主要国別のタクロリムスAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のタクロリムスAPI市場規模（タイプ別、アプリケーション別） - 主要国別のタクロリムスAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のタクロリムスAPI市場規模（タイプ別、アプリケーション別） - 主要国別のタクロリムスAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのタクロリムスAPI市場規模（タイプ別、アプリケーション別） - 主要国別のタクロリムスAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hangzhou Zhongmei Huadong Pharmaceutical、Guangzhou Tosun Pharmaceutical、Chunghwa Chemical Synthesis & Biotech、ChemWerth Inc、Dr. Reddy's Laboratories、Zeon Health Industries、Fishfa Biogenics、Teva API、Apotex Fermentation Inc.、Astellas Pharma、Bills Biotech、CKD Bio Corporation、Concord Biotech、JOYANG LABORATORIES、Lek Pharmaceuticals、Murli Krishna Pharma、Viruj Pharmaceuticals Pvt. Ltd、Zhejiang Hisun Pharmaceutical ・産業チェーン及び販売チャネル分析 - タクロリムスAPIの産業チェーン分析 - タクロリムスAPIの原材料 - タクロリムスAPIの生産プロセス - タクロリムスAPIの販売及びマーケティング - タクロリムスAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - タクロリムスAPIの産業動向 - タクロリムスAPIのマーケットドライバー - タクロリムスAPIの課題 - タクロリムスAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Tacrolimus API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Tacrolimus API include Hangzhou Zhongmei Huadong Pharmaceutical, Guangzhou Tosun Pharmaceutical, Chunghwa Chemical Synthesis & Biotech, ChemWerth Inc, Dr. Reddy’s Laboratories, Zeon Health Industries, Fishfa Biogenics, Teva API and Apotex Fermentation Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Tacrolimus API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Tacrolimus API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tacrolimus API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Tacrolimus API market. Further, it explains the major drivers and regional dynamics of the global Tacrolimus API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hangzhou Zhongmei Huadong Pharmaceutical
Guangzhou Tosun Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
Dr. Reddy’s Laboratories
Zeon Health Industries
Fishfa Biogenics
Teva API
Apotex Fermentation Inc.
Astellas Pharma
Bills Biotech
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Lek Pharmaceuticals
Murli Krishna Pharma
Viruj Pharmaceuticals Pvt. Ltd
Zhejiang Hisun Pharmaceutical
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Tacrolimus API Segment by Purity
0.98
0.99
Others
Tacrolimus API Segment by Application
Capsules
Injection
Ointments
Eye Drops
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Tacrolimus API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tacrolimus API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Tacrolimus API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Tacrolimus API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Tacrolimus API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tacrolimus API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Tacrolimus API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Tacrolimus API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hangzhou Zhongmei Huadong Pharmaceutical, Guangzhou Tosun Pharmaceutical, Chunghwa Chemical Synthesis & Biotech, ChemWerth Inc, Dr. Reddy’s Laboratories, Zeon Health Industries, Fishfa Biogenics, Teva API and Apotex Fermentation Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Tacrolimus API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Tacrolimus API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Tacrolimus API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tacrolimus API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Tacrolimus API Product Introduction
1.2 Market by Purity
1.2.1 Global Tacrolimus API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tacrolimus API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Capsules
1.3.3 Injection
1.3.4 Ointments
1.3.5 Eye Drops
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Tacrolimus API Production
2.1 Global Tacrolimus API Production Capacity (2017-2028)
2.2 Global Tacrolimus API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Tacrolimus API Production by Region
2.3.1 Global Tacrolimus API Historic Production by Region (2017-2022)
2.3.2 Global Tacrolimus API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Tacrolimus API Sales in Volume & Value Estimates and Forecasts
3.1 Global Tacrolimus API Sales Estimates and Forecasts 2017-2028
3.2 Global Tacrolimus API Revenue Estimates and Forecasts 2017-2028
3.3 Global Tacrolimus API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Tacrolimus API Sales by Region
3.4.1 Global Tacrolimus API Sales by Region (2017-2022)
3.4.2 Global Sales Tacrolimus API by Region (2023-2028)
3.5 Global Tacrolimus API Revenue by Region
3.5.1 Global Tacrolimus API Revenue by Region (2017-2022)
3.5.2 Global Tacrolimus API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Tacrolimus API Production Capacity by Manufacturers
4.2 Global Tacrolimus API Sales by Manufacturers
4.2.1 Global Tacrolimus API Sales by Manufacturers (2017-2022)
4.2.2 Global Tacrolimus API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Tacrolimus API in 2021
4.3 Global Tacrolimus API Revenue by Manufacturers
4.3.1 Global Tacrolimus API Revenue by Manufacturers (2017-2022)
4.3.2 Global Tacrolimus API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Tacrolimus API Revenue in 2021
4.4 Global Tacrolimus API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Tacrolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Tacrolimus API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Tacrolimus API Sales by Purity
5.1.1 Global Tacrolimus API Historical Sales by Purity (2017-2022)
5.1.2 Global Tacrolimus API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Tacrolimus API Sales Market Share by Purity (2017-2028)
5.2 Global Tacrolimus API Revenue by Purity
5.2.1 Global Tacrolimus API Historical Revenue by Purity (2017-2022)
5.2.2 Global Tacrolimus API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Tacrolimus API Revenue Market Share by Purity (2017-2028)
5.3 Global Tacrolimus API Price by Purity
5.3.1 Global Tacrolimus API Price by Purity (2017-2022)
5.3.2 Global Tacrolimus API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Tacrolimus API Sales by Application
6.1.1 Global Tacrolimus API Historical Sales by Application (2017-2022)
6.1.2 Global Tacrolimus API Forecasted Sales by Application (2023-2028)
6.1.3 Global Tacrolimus API Sales Market Share by Application (2017-2028)
6.2 Global Tacrolimus API Revenue by Application
6.2.1 Global Tacrolimus API Historical Revenue by Application (2017-2022)
6.2.2 Global Tacrolimus API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Tacrolimus API Revenue Market Share by Application (2017-2028)
6.3 Global Tacrolimus API Price by Application
6.3.1 Global Tacrolimus API Price by Application (2017-2022)
6.3.2 Global Tacrolimus API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Tacrolimus API Market Size by Purity
7.1.1 North America Tacrolimus API Sales by Purity (2017-2028)
7.1.2 North America Tacrolimus API Revenue by Purity (2017-2028)
7.2 North America Tacrolimus API Market Size by Application
7.2.1 North America Tacrolimus API Sales by Application (2017-2028)
7.2.2 North America Tacrolimus API Revenue by Application (2017-2028)
7.3 North America Tacrolimus API Sales by Country
7.3.1 North America Tacrolimus API Sales by Country (2017-2028)
7.3.2 North America Tacrolimus API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Tacrolimus API Market Size by Purity
8.1.1 Europe Tacrolimus API Sales by Purity (2017-2028)
8.1.2 Europe Tacrolimus API Revenue by Purity (2017-2028)
8.2 Europe Tacrolimus API Market Size by Application
8.2.1 Europe Tacrolimus API Sales by Application (2017-2028)
8.2.2 Europe Tacrolimus API Revenue by Application (2017-2028)
8.3 Europe Tacrolimus API Sales by Country
8.3.1 Europe Tacrolimus API Sales by Country (2017-2028)
8.3.2 Europe Tacrolimus API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tacrolimus API Market Size by Purity
9.1.1 Asia Pacific Tacrolimus API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Tacrolimus API Revenue by Purity (2017-2028)
9.2 Asia Pacific Tacrolimus API Market Size by Application
9.2.1 Asia Pacific Tacrolimus API Sales by Application (2017-2028)
9.2.2 Asia Pacific Tacrolimus API Revenue by Application (2017-2028)
9.3 Asia Pacific Tacrolimus API Sales by Region
9.3.1 Asia Pacific Tacrolimus API Sales by Region (2017-2028)
9.3.2 Asia Pacific Tacrolimus API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Tacrolimus API Market Size by Purity
10.1.1 Latin America Tacrolimus API Sales by Purity (2017-2028)
10.1.2 Latin America Tacrolimus API Revenue by Purity (2017-2028)
10.2 Latin America Tacrolimus API Market Size by Application
10.2.1 Latin America Tacrolimus API Sales by Application (2017-2028)
10.2.2 Latin America Tacrolimus API Revenue by Application (2017-2028)
10.3 Latin America Tacrolimus API Sales by Country
10.3.1 Latin America Tacrolimus API Sales by Country (2017-2028)
10.3.2 Latin America Tacrolimus API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tacrolimus API Market Size by Purity
11.1.1 Middle East and Africa Tacrolimus API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Tacrolimus API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Tacrolimus API Market Size by Application
11.2.1 Middle East and Africa Tacrolimus API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Tacrolimus API Revenue by Application (2017-2028)
11.3 Middle East and Africa Tacrolimus API Sales by Country
11.3.1 Middle East and Africa Tacrolimus API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Tacrolimus API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hangzhou Zhongmei Huadong Pharmaceutical
12.1.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
12.1.2 Hangzhou Zhongmei Huadong Pharmaceutical Overview
12.1.3 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
12.2 Guangzhou Tosun Pharmaceutical
12.2.1 Guangzhou Tosun Pharmaceutical Corporation Information
12.2.2 Guangzhou Tosun Pharmaceutical Overview
12.2.3 Guangzhou Tosun Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Guangzhou Tosun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
12.3 Chunghwa Chemical Synthesis & Biotech
12.3.1 Chunghwa Chemical Synthesis & Biotech Corporation Information
12.3.2 Chunghwa Chemical Synthesis & Biotech Overview
12.3.3 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Chunghwa Chemical Synthesis & Biotech Recent Developments
12.4 ChemWerth Inc
12.4.1 ChemWerth Inc Corporation Information
12.4.2 ChemWerth Inc Overview
12.4.3 ChemWerth Inc Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 ChemWerth Inc Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 ChemWerth Inc Recent Developments
12.5 Dr. Reddy’s Laboratories
12.5.1 Dr. Reddy’s Laboratories Corporation Information
12.5.2 Dr. Reddy’s Laboratories Overview
12.5.3 Dr. Reddy’s Laboratories Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Dr. Reddy’s Laboratories Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Dr. Reddy’s Laboratories Recent Developments
12.6 Zeon Health Industries
12.6.1 Zeon Health Industries Corporation Information
12.6.2 Zeon Health Industries Overview
12.6.3 Zeon Health Industries Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Zeon Health Industries Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Zeon Health Industries Recent Developments
12.7 Fishfa Biogenics
12.7.1 Fishfa Biogenics Corporation Information
12.7.2 Fishfa Biogenics Overview
12.7.3 Fishfa Biogenics Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Fishfa Biogenics Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Fishfa Biogenics Recent Developments
12.8 Teva API
12.8.1 Teva API Corporation Information
12.8.2 Teva API Overview
12.8.3 Teva API Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Teva API Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Teva API Recent Developments
12.9 Apotex Fermentation Inc.
12.9.1 Apotex Fermentation Inc. Corporation Information
12.9.2 Apotex Fermentation Inc. Overview
12.9.3 Apotex Fermentation Inc. Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Apotex Fermentation Inc. Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Apotex Fermentation Inc. Recent Developments
12.10 Astellas Pharma
12.10.1 Astellas Pharma Corporation Information
12.10.2 Astellas Pharma Overview
12.10.3 Astellas Pharma Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Astellas Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Astellas Pharma Recent Developments
12.11 Bills Biotech
12.11.1 Bills Biotech Corporation Information
12.11.2 Bills Biotech Overview
12.11.3 Bills Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Bills Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Bills Biotech Recent Developments
12.12 CKD Bio Corporation
12.12.1 CKD Bio Corporation Corporation Information
12.12.2 CKD Bio Corporation Overview
12.12.3 CKD Bio Corporation Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 CKD Bio Corporation Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 CKD Bio Corporation Recent Developments
12.13 Concord Biotech
12.13.1 Concord Biotech Corporation Information
12.13.2 Concord Biotech Overview
12.13.3 Concord Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Concord Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Concord Biotech Recent Developments
12.14 JOYANG LABORATORIES
12.14.1 JOYANG LABORATORIES Corporation Information
12.14.2 JOYANG LABORATORIES Overview
12.14.3 JOYANG LABORATORIES Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 JOYANG LABORATORIES Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 JOYANG LABORATORIES Recent Developments
12.15 Lek Pharmaceuticals
12.15.1 Lek Pharmaceuticals Corporation Information
12.15.2 Lek Pharmaceuticals Overview
12.15.3 Lek Pharmaceuticals Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Lek Pharmaceuticals Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Lek Pharmaceuticals Recent Developments
12.16 Murli Krishna Pharma
12.16.1 Murli Krishna Pharma Corporation Information
12.16.2 Murli Krishna Pharma Overview
12.16.3 Murli Krishna Pharma Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Murli Krishna Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Murli Krishna Pharma Recent Developments
12.17 Viruj Pharmaceuticals Pvt. Ltd
12.17.1 Viruj Pharmaceuticals Pvt. Ltd Corporation Information
12.17.2 Viruj Pharmaceuticals Pvt. Ltd Overview
12.17.3 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Viruj Pharmaceuticals Pvt. Ltd Recent Developments
12.18 Zhejiang Hisun Pharmaceutical
12.18.1 Zhejiang Hisun Pharmaceutical Corporation Information
12.18.2 Zhejiang Hisun Pharmaceutical Overview
12.18.3 Zhejiang Hisun Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Zhejiang Hisun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Zhejiang Hisun Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Tacrolimus API Industry Chain Analysis
13.2 Tacrolimus API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Tacrolimus API Production Mode & Process
13.4 Tacrolimus API Sales and Marketing
13.4.1 Tacrolimus API Sales Channels
13.4.2 Tacrolimus API Distributors
13.5 Tacrolimus API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Tacrolimus API Industry Trends
14.2 Tacrolimus API Market Drivers
14.3 Tacrolimus API Market Challenges
14.4 Tacrolimus API Market Restraints
15 Key Finding in The Global Tacrolimus API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer